论文信息 - Clinical activity, safety, and biomarkers of MPDL3280A, an engineered PD-L1 antibody in patients with metastatic renal cell carcinoma (mRCC). - 字舞流文

Clinical activity, safety, and biomarkers of MPDL3280A, an engineered PD-L1 antibody in patients with metastatic renal cell carcinoma (mRCC).

T. Powles | J. Sosman | M. Sznol | D. Cho | G. Fine | O. Hamid | D. McDermott | M. Gordon | A. Hollebecque | M. Kowanetz | A. Mokatrin | J. Delord | R. Funke | I. Rhee